These aim to boost effectiveness and convenience even further, potentially changing how we approach long-term weight management
If you get these while on a GLP-1 drug, stop the drug and go to emergency care right away
Hypoglycemia: Although cagrilintide alone does not typically cause dangerously low blood sugar, patients who are also taking insulin or other glucose-lowering medications should be aware of the combined risk
Empagliflozin alleviates atherosclerosis progression by inhibiting inflammation and sympathetic activity in a normoglycemic mouse model
Ozempic Was Used by Two Million Medicare Part D Enrollees in 2024, Up from Fewer Than 150,000 in 2019 Semaglutide, the GLP-1 drug branded as Ozempic, Rybelsus, and Wegovy, was the most used GLP-1 in 2024